
@ShahidNShah
New AI startups are facing difficulty getting off the ground even as the industry leans hard into the technology.
Artificial intelligence is poised to become a major force in healthcare. The technology is developing at breakneck speed, and both payers and providers are examining the potential use cases, with one survey from November showing 73% of organizations plan on growing their financial commitments to the technology. But because AI is so new, there are still some knots left to be untangled.
One of the biggest knots is reimbursement – specifically, the reimbursement of new AI-driven devices and processes. Reimbursement is paramount to improving access to advanced tools, but even for FDA-cleared devices, the path to reimbursement for these technologies is unclear and slow-moving.
Read on healthcarefinancenews.com
Continue reading at healthcarefinancenews.com
In a bustling hospital, a surgeon reaches for a vital piece of equipment only to find it unavailable. Meanwhile, in another corner of the facility, a storeroom is brimming with expired medical …
Posted Dec 31, 2024 Fundamental Technologies Health Technology Healthcare
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Feb 21, 2025 at 1:11pm